Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ACC Highlights: Better Stents, But Are Stents Often Necessary?

Executive Summary

The 56th Annual American College of Cardiology conference provided the expected clinical trial updates on a variety of interventional devices. But the most anticipated and surprising news of the meeting came from the COURAGE study, whose results broke against the tide of using interventional procedures and stents as primary therapy for stable coronary artery disease.

You may also be interested in...



AHA Highlights: Improving Patient Care

The American Heart Association's scientific sessions in November 2007 presented new clinical data on drug-eluting stents, cardiac resynchronization, treatments for acute coronary syndrome, and better ways of diagnosing and treating myocardial infarction.

AHA Highlights: Improving Patient Care

The American Heart Association's scientific sessions in November 2007 presented new clinical data on drug-eluting stents, cardiac resynchronization, treatments for acute coronary syndrome, and better ways of diagnosing and treating myocardial infarction.

Stent Recap: Turmoil in 2007--What's Ahead for Interventional Cardiology?

Although safety concerns about drug-eluting stents have been mitigated somewhat by recent reports of more positive clinical data, there is lingering unease and confusion in the cardiology community about when, how, and in whom to use these devices. There is also a growing wave of healthy skepticism about the way stent trials are designed and conducted, and whether evidence- based medicine is well served by the current process.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT035068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel